186 related articles for article (PubMed ID: 498582)
1. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
[TBL] [Abstract][Full Text] [Related]
2. Liver membrane autoantibodies: methods for their detection and clinical significance.
Nagai S; Manns M; Meyer zum Büschenfelde KH
Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
[TBL] [Abstract][Full Text] [Related]
5. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
[TBL] [Abstract][Full Text] [Related]
7. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
Hopf U; Meyer zum Büschenfelde KH; Arnold W
N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
[TBL] [Abstract][Full Text] [Related]
8. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
Ortona L; Laghi V; Cauda R; Nervo P
Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
[TBL] [Abstract][Full Text] [Related]
9. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
[TBL] [Abstract][Full Text] [Related]
10. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
Sundin U; Heigl Z; Sundqvist KG
Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
Kakumu S; Hara T; Gohji H; Sakamoto N
Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Cauda R; Nervo P
Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.
Manns M; Meyer zum Büschenfelde KH; Hütteroth TH; Hess G
Clin Exp Immunol; 1980 Nov; 42(2):263-72. PubMed ID: 6781800
[TBL] [Abstract][Full Text] [Related]
14. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
[TBL] [Abstract][Full Text] [Related]
15. [Direct and induced lymphocytotoxicity to rabbit hepatocytes in chronic active hepatitis].
Laghi V; Cauda R; Nervo P
Arch Sci Med (Torino); 1980; 137(4):575-7. PubMed ID: 7247672
[TBL] [Abstract][Full Text] [Related]
16. Detection and clinical significance of acetone-insoluble liver cell membrane antigen in sera of patients with chronic active liver diseases.
Tsuji T; Takahashi K; Sawahara M; Matsuura E; Yamamoto I
Gastroenterol Jpn; 1985 Feb; 20(1):37-47. PubMed ID: 4040488
[TBL] [Abstract][Full Text] [Related]
17. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.
Frazer IH; Mackay IR
Clin Exp Immunol; 1984 Aug; 57(2):429-37. PubMed ID: 6432384
[TBL] [Abstract][Full Text] [Related]
19. [Immunology of liver diseases].
Meyer zum Büschenfelde KH
Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies to liver membrane in children with chronic active hepatitis (author's transl)].
Chauvel Y; Fernandez-Tello DS; Frommel D
Arch Fr Pediatr; 1980; 37 Suppl 2():V-VII. PubMed ID: 7447613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
